RMD 0.54% $37.28 resmed inc

Resmed, page-10

  1. 406 Posts.
    Respironics ( RESP ) is RMD only competitor in the APNEA disorder arena . Both control 99% of the world market . A new ( ALLEGEDLY ) entrant has been named about 6 months ago . As foreshadowed at the time , the entrant was the excuse the market used to mark RMD down from its high valuation . Period . Current weakness stemmed from general bad sentiment in the USA ( RMD is primarily an American stock ) equities markets , its past hi valuation ( not anymore though ) and a recent change in the German PBS and the recent appreciation of the A$ v US$ . RMD is the technological leader in this field . No one is even closer to its high standard . It is the "TRINTRON" of the apnea market !

    RMD will kick back big time IMHO . It is only a matter of time . Duff
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.